...
首页> 外文期刊>Cell death & disease. >Imidazoacridinone-dependent lysosomal photodestruction: a pharmacological Trojan horse approach to eradicate multidrug-resistant cancers
【24h】

Imidazoacridinone-dependent lysosomal photodestruction: a pharmacological Trojan horse approach to eradicate multidrug-resistant cancers

机译:咪唑并rid啶酮依赖性溶酶体光解:根除多药耐药癌症的药理木马方法

获取原文
           

摘要

Multidrug resistance (MDR) remains a primary hindrance to curative cancer therapy. Thus, introduction of novel strategies to overcome MDR is of paramount therapeutic significance. Sequestration of chemotherapeutics in lysosomes is an established mechanism of drug resistance. Here, we show that MDR cells display a marked increase in lysosome number. We further demonstrate that imidazoacridinones (IAs), which are cytotoxic fluorochromes, undergo a dramatic compartmentalization in lysosomes because of their hydrophobic weak base nature. We hence developed a novel photoactivation-based pharmacological Trojan horse approach to target and eradicate MDR cancer cells based on photo-rupture of IA-loaded lysosomes and tumor cell lysis via formation of reactive oxygen species. Illumination of IA-loaded cells resulted in lysosomal photodestruction and restoration of parental cell drug sensitivity. Lysosomal photodestruction of MDR cells overexpressing the key MDR efflux transporters ABCG2, ABCB1 or ABCC1 resulted in 10- to 52-fold lower IC50 values of various IAs, thereby restoring parental cell sensitivity. Finally, in vivo application of this photodynamic therapy strategy after i.v. injection of IAs in human ovarian tumor xenografts in the chorioallantoic membrane model revealed selective destruction of tumors and their associated vasculature. These findings identify lysosomal sequestration of IAs as an Achilles heel of MDR cells that can be harnessed to eradicate MDR tumor cells via lysosomal photodestruction.. ? 2012 Macmillan Publishers Limited
机译:多药耐药性(MDR)仍然是治愈性癌症治疗的主要障碍。因此,引入克服MDR的新策略具有最重要的治疗意义。溶酶体中化学疗法的隔离是已建立的耐药性机制。在这里,我们显示MDR细胞的溶酶体数目显着增加。我们进一步证明,咪唑并rid啶酮(IAs)是细胞毒性的荧光染料,由于其疏水性弱的碱基性质,在溶酶体中经历了显着的区室化。因此,我们开发了一种新型的基于光活化的药理性特洛伊木马方法,以基于IA加载的溶酶体的光破坏和通过活性氧物质形成的肿瘤细胞裂解来靶向和根除MDR癌细胞。 IA加载细胞的照明导致溶酶体光解和亲代细胞药物敏感性的恢复。过度表达关键MDR外排转运蛋白ABCG2,ABCB1或ABCC1的MDR细胞的溶酶体光解作用导致各种IA的IC50值降低10至52倍,从而恢复了亲代细胞的敏感性。最后,在静脉注射后在体内应用这种光动力疗法策略。在绒毛膜尿囊膜模型中向人卵巢肿瘤异种移植物中注射IAs显示出肿瘤及其相关脉管系统的选择性破坏。这些发现将IA的溶酶体隔离作为MDR细胞的致命弱点,可以通过溶酶体的光解作用来根除MDR肿瘤细胞。 2012 Macmillan Publishers Limited

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号